--News Direct--
Imugene Ltd (ASX:IMU, OTC:IUGNF) CEO Leslie Chong tells Proactive it has been a busy and productive start to the new year with a number of presentations including at the JP Morgan Healthcare Conference. The company also presented an oral abstract and several poster sessions on its HER-Vaxx and CF33 technologies at the ASCO Gastrointestinal Cancers Symposium in the US.
Contact Details
Proactive Investors
Jonathan Jackson
+61 413 713 744
Jonathan@proactiveinvestors.com
View source version on newsdirect.com: https://newsdirect.com/news/imugene-off-to-strong-start-to-2023-with-jp-morgan-healthcare-conference-728345099
